Methyl 6-amino-5-bromo-3-chloropyridine-2-carboxylate

Catalog No. :
ACGEFW713
CAS No. :
577691-68-0
Molecular Formula :
C7H6BrClN2O2
Molecular Weight :
265.49

IUPAC Name:methyl 6-amino-5-bromo-3-chloropicolinate

Methyl 6-amino-5-bromo-3-chloropyridine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$175.00Login to see priceInquiryInquiry
5g98%$641.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 6-amino-5-bromo-3-chloropyridine-2-carboxylate
IUPAC Namemethyl 6-amino-5-bromo-3-chloropicolinate
MDL No.MFCD28128287
Molecular FormulaC7H6BrClN2O2
Molecular Weight265.49
SMILESO=C(C1=NC(N)=C(Br)C=C1Cl)OC
InChI KeyWRVXVTUGOFOAIW-UHFFFAOYSA-N
SynonymMethyl 6-aMino-5-broMo-3-chloropicolinate;2-Pyridinecarboxylic acid, 6-amino-5-bromo-3-chloro-, methyl ester
CAS No.577691-68-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACGEFW713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNOJU136 route compound structure diagram
    ACNOJU136178876-82-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGEFW713 route product structure diagram
    ACGEFW713577691-68-0
Inquiry

2. ACGEFW713 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCZIU451 route compound structure diagram
    ACCZIU451563-67-7 In Stock
  2. Plus
  3. ACNOJU136 route compound structure diagram
    ACNOJU136178876-82-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACGEFW713 route product structure diagram
    ACGEFW713577691-68-0
Inquiry

Comments (0)